Back to Search
Start Over
[First causally effective drug against Alzheimer's? : The FDA approves aducanumab].
- Source :
-
Der Nervenarzt [Nervenarzt] 2022 Apr; Vol. 93 (4), pp. 410-412. Date of Electronic Publication: 2021 Sep 07. - Publication Year :
- 2022
Details
- Language :
- German
- ISSN :
- 1433-0407
- Volume :
- 93
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Der Nervenarzt
- Publication Type :
- Academic Journal
- Accession number :
- 34494135
- Full Text :
- https://doi.org/10.1007/s00115-021-01182-1